CORNEA, cilt.27, sa.2, ss.193-195, 2008 (SCI İndekslerine Giren Dergi)
Purpose: To report the efficacy of topical cyclosporine A (CsA) 0.05% drops (Restasis; Allergan, Irvine, CA) in the treatment of superior limbic keratoconjunctivitis (SLK).